Skip to main content
Clinical Trials/NCT02455102
NCT02455102
Completed
Not Applicable

Electronic Warning System to Improve Stroke Prevention in Atrial Fibrillation - A Quality Improvement Initiative at the University Hospital Bern

Insel Gruppe AG, University Hospital Bern1 site in 1 country1,707 target enrollmentSeptember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
1707
Locations
1
Primary Endpoint
Rate of initiation of adequate measures to prevent stroke (oral anticoagulant prescription) by physician in charge
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The aim of this randomized controlled study is to evaluate whether a newly designed electronic warning system will increase the initiation rate of adequate stroke preventive measures in patients with atrial fibrillation.

Detailed Description

A large proportion of patients with atrial fibrillation do not receive stroke prevention therapy in line with the guidelines, in spite of the presence of an increased risk of stroke. It will be investigated whether an electronic alert to physicians, whose patients with atrial fibrillation do not receive stroke preventive measures, will increase the rate of adequate stroke preventive measures as compared to a control group of patients without an electronic alert. The electronic alerts will be sent if patients with atrial fibrillation but without adequate stroke preventive measures receive in-patient treatment at the University Hospital Bern. The electronic alert system includes a feature that helps the physicians in charge to evaluate the CHA2DS2VASC Score. At the end of the hospital stay medical discharge letters will be reviewed for initiation of adequate stroke preventive measures.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
October 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All in-patients with atrial fibrillation

Exclusion Criteria

  • Ongoing anticoagulant therapy

Outcomes

Primary Outcomes

Rate of initiation of adequate measures to prevent stroke (oral anticoagulant prescription) by physician in charge

Time Frame: End of hospital stay (expected average duration of 1 week)

Reviewed from discharge letter

Secondary Outcomes

  • Use of the CHA2DS2VASc score calculation tool by the physician in charge(During hospital stay (expected average duration of 1 week))
  • Rate of correct evaluation of the CHA2DS2VASC Score through the calculation tool by physician in charge(End of hospital stay (expected average duration of 1 week))

Study Sites (1)

Loading locations...

Similar Trials